Company intelligence / Profile preview

Henogen

Seneffe, Belgiumorpha.net ↗
Ownership
Private
Employees
~400
Development stage
Commercial
01

Overview

Henogen is a leading European contract manufacturer specializing in viral vectors for gene therapies and vaccines. It was acquired by Thermo Fisher Scientific in January 2021 for approximately $875 million. The company operates two advanced facilities in Belgium with over 7,000 m² of clinical and commercial capacity and about 400 employees. Its expertise spans multiple classes of viral vectors used by global biopharma clients to develop advanced therapeutics, including COVID-19 vaccines.

Therapeutic areas
Infectious Diseases
Modalities
Viral vectorBiologic
Industry
Contract Manufacturing Organization
02

Partnerships

Previously partnered with AstraZeneca to support large-scale adenovirus vector production for the company's COVID-19 vaccine candidate prior to acquisition by Thermo Fisher.Other partnerships are typically confidential due to CDMO business model.

Beyond the preview

Go deeper on Henogen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Henogen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call